News
Pfizer (NYSE: PFE) is a case in point, with its forward dividend yield of 7%. Although the stock is a favorite for many ...
Pfizer (PFE) stock and BioNTech (BNTX) stock in focus as FDA may not renew the authorization for their pediatric COVID shot. Read more here.
GSK and CureVac will together receive $740 million, as well as royalties on sales of COVID-19 vaccines in the US ...
14hon MSN
Vaccinating young children against Covid-19 may be more challenging this respiratory virus season
Parents in the United States who want to vaccinate their young children against Covid-19 this fall may face a growing set of ...
Shortly after that, the CDC overhauled its vaccine recommendations in COVID, nixing its endorsement of the shots for pregnant women and healthy children. At the time, RFK Jr. said he “couldn’t be more ...
Six months into Donald Trump’s second term, his administration is at war with the federal judiciary, evading court orders ...
Pediatrician Deborah Greenhouse writes that South Carolina is at risk because of the U.S. government’s decision to defund almost $500 million in mRNA vaccine research funding.
5h
MONTCO Today on MSNWSJ: GSK to Receive $370M in CureVac-BioNTech Vaccine Dispute
Glaxosmithkline, which has major operations in Montgomery County, is set to receive a major settlement, writes Anthony O. Goriainoff for the Wall Street Journal. The pharmaceutical powerhouse will ...
U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced last week that his department would slash about $500 ...
The research, done in mice and in human cells, shows that a protein called STUB1 restrains the immune system’s elite ...
Stock index futures jumped on Tuesday, as the July retail inflation report came largely in line, but core CPI was slightly ...
Summit Therapeutics, which has consistently been communicating quarterly results through investor calls in the past few years ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results